Literature DB >> 19428498

Rodent models of insomnia: a review of experimental procedures that induce sleep disturbances.

Florent G Revel1, Juergen Gottowik, Sylvia Gatti, Joseph G Wettstein, Jean-Luc Moreau.   

Abstract

Insomnia, the most common sleep disorder, is characterized by persistent difficulty in falling or staying asleep despite adequate opportunity to sleep, leading to daytime fatigue and mental dysfunction. As sleep is a sophisticated physiological process generated by a network of neuronal systems that cannot be reproduced in-vitro, pre-clinical development of hypnotic drugs requires in-vivo investigations. Accordingly, this review critically evaluates current and putative rodent models of insomnia which could be used to screen novel hypnotics. Only few valid insomnia models are currently available, although many experimental conditions lead to disturbance of physiological sleep. We categorized these conditions as a function of the procedure used to induce perturbation of sleep, and we discuss their respective advantages and pitfalls with respect to validity, feasibility and translational value to human research.

Entities:  

Mesh:

Year:  2009        PMID: 19428498     DOI: 10.1016/j.neubiorev.2009.03.002

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  26 in total

Review 1.  The impact of stress on sleep: Pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders.

Authors:  David A Kalmbach; Jason R Anderson; Christopher L Drake
Journal:  J Sleep Res       Date:  2018-05-24       Impact factor: 3.981

Review 2.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 3.  Sleep-Wake Disorders in Stroke-Increased Stroke Risk and Deteriorated Recovery? An Evaluation on the Necessity for Prevention and Treatment.

Authors:  Simone B Duss; Anne-Kathrin Brill; Panagiotis Bargiotas; Laura Facchin; Filip Alexiev; Mauro Manconi; Claudio L Bassetti
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-07       Impact factor: 5.081

4.  The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.

Authors:  Roberto Frau; Valentina Bini; Alessio Soggiu; Simona Scheggi; Alessandra Pardu; Silvia Fanni; Paola Roncada; Monica Puligheddu; Francesco Marrosu; Donatella Caruso; Paola Devoto; Marco Bortolato
Journal:  Neuropsychopharmacology       Date:  2017-02-15       Impact factor: 7.853

Review 5.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

6.  Chronic alcohol exposure reduces acetylated histones in the sleep-wake regulatory brain regions to cause insomnia during withdrawal.

Authors:  Rishi Sharma; Pradeep Sahota; Mahesh M Thakkar
Journal:  Neuropharmacology       Date:  2020-09-19       Impact factor: 5.250

7.  Novel environment influences the effect of paradoxical sleep deprivation upon brain and peripheral cytokine gene expression.

Authors:  Noah T Ashley; David W Sams; Audrey C Brown; Jennifer E Dumaine
Journal:  Neurosci Lett       Date:  2016-01-19       Impact factor: 3.046

8.  [Insomnia--state of the science].

Authors:  D Riemann; C Baglioni; B Feige; K Spiegelhalder
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

Review 9.  Neurobehavioural complications of sleep deprivation: Shedding light on the emerging role of neuroactive steroids.

Authors:  Roberto Frau; Francesco Traccis; Marco Bortolato
Journal:  J Neuroendocrinol       Date:  2019-09-30       Impact factor: 3.627

10.  Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice.

Authors:  Elise Gondard; Christelle Anaclet; Hidéo Akaoka; Rui-Xian Guo; Mei Zhang; Colette Buda; Patricia Franco; Hidehito Kotani; Jian-Sheng Lin
Journal:  Neuropsychopharmacology       Date:  2013-01-02       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.